Literature DB >> 16843432

Sphingolipid metabolism in neural cells.

Gerhild van Echten-Deckert1, Thomas Herget.   

Abstract

Sphingolipids were discovered more than a century ago in the brain. Cerebrosides and sphingomyelins were named so because they were first isolated from neural tissue. Although glycosphingolipids and especially those containing sialic acid in their oligosaccharide moiety are particularly abundant in the brain, sphingolipids are ubiquitous cellular membrane components. They form cell- and species-specific profiles at the cell surfaces that characteristically change in development, differentiation, and oncogenic transformation, indicating the significance of these lipid molecules for cell-cell and cell-matrix interactions as well as for cell adhesion, modulation of membrane receptors and signal transduction. This review summarizes sphingolipid metabolism with emphasis on aspects particularly relevant in neural cell types, including neurons, oligodendrocytes and neuroblastoma cells. In addition, the reader is briefly introduced into the methodology of lipid evaluation techniques and also into the putative physiological functions of glycosphingolipids and their metabolites in neural tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16843432     DOI: 10.1016/j.bbamem.2006.06.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  46 in total

1.  Harnessing the power of yeast to elucidate the role of sphingolipids in metabolic and signaling processes pertinent to psychiatric disorders.

Authors:  Shyamalagauri Jadhav; Miriam L Greenberg
Journal:  Clin Lipidol       Date:  2014-11-01

2.  Sphingosine 1-phosphate (S1P) lyase deficiency increases sphingolipid formation via recycling at the expense of de novo biosynthesis in neurons.

Authors:  Nadine Hagen-Euteneuer; Dieter Lütjohann; Hyejung Park; Alfred H Merrill; Gerhild van Echten-Deckert
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

3.  The distribution of the proteoglycan FORSE-1 in the developing mouse central nervous system.

Authors:  Albert Kelly; Aisling O'Malley; Mohammad Redha; Gerard W O'Keeffe; Denis S Barry
Journal:  J Anat       Date:  2018-11-25       Impact factor: 2.610

Review 4.  The role of sphingolipids in psychoactive drug use and addiction.

Authors:  Liubov S Kalinichenko; Erich Gulbins; Johannes Kornhuber; Christian P Müller
Journal:  J Neural Transm (Vienna)       Date:  2018-01-10       Impact factor: 3.575

5.  Preparation of (13)C-labeled ceramide by acetic acid bacteria and its incorporation in mice.

Authors:  Hiroyuki Fukami; Hideki Tachimoto; Mikiya Kishi; Takayuki Kaga; Hatsue Waki; Machiko Iwamoto; Yasukazu Tanaka
Journal:  J Lipid Res       Date:  2010-07-23       Impact factor: 5.922

6.  Assessment of altered lipid homeostasis by HILIC-ion mobility-mass spectrometry-based lipidomics.

Authors:  Kelly M Hines; Josi Herron; Libin Xu
Journal:  J Lipid Res       Date:  2017-02-06       Impact factor: 5.922

7.  Deficiency of sphingosine-1-phosphate lyase impairs lysosomal metabolism of the amyloid precursor protein.

Authors:  Ilker Karaca; Irfan Y Tamboli; Konstantin Glebov; Josefine Richter; Lisa H Fell; Marcus O Grimm; Viola J Haupenthal; Tobias Hartmann; Markus H Gräler; Gerhild van Echten-Deckert; Jochen Walter
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

8.  Ceramide signaling in cancer and stem cells.

Authors:  Erhard Bieberich
Journal:  Future Lipidol       Date:  2008-06

Review 9.  An introduction to sphingolipid metabolism and analysis by new technologies.

Authors:  Yanfeng Chen; Ying Liu; M Cameron Sullards; Alfred H Merrill
Journal:  Neuromolecular Med       Date:  2010-08-03       Impact factor: 3.843

10.  Long-chain ceramide produced in response to N-hexanoylsphingosine does not induce apoptosis in CHP-100 cells.

Authors:  Adriano Mancinetti; Sabrina Di Bartolomeo; Angelo Spinedi
Journal:  Lipids       Date:  2009-09-26       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.